Stephanie Kelly

A landmark partnership aims to tap Australia's vast Beetaloo gas reserves for domestic use and LNG export, igniting both economic hopes and fierce opposition.

LiveOnNY launches an emotional ad campaign using a classic song to address New York's critical shortage of registered organ donors. But is a song enough?

A new AAUW report shows women earn just 81 cents for every dollar men make, a gap present in every US district that costs women over half a million dollars.

With new CTO Kouros Esfahany, Locality aims to merge broadcast and streaming, promising a smarter, more efficient way to reach local audiences.

Amidst an energy crisis, DoGo Power launches its GFM Smart PV & ESS solution in South Africa, promising grid independence and lower costs for businesses.

Québec City's airport is launching a massive $47.8M expansion to double domestic capacity, ease congestion, and fuel the region's economic ambitions.

SciTech's ST-001 overcomes a decades-old barrier for fenretinide, showing promising results for Cutaneous T-Cell Lymphoma patients in early trials.

Maze Therapeutics posts positive Phase 2 data for its genetic kidney disease drug, but a sharp stock drop reveals investor concerns in a competitive race.

With AI driving record demand, Vantage Data Centers brings in a finance heavyweight to oversee its massive global expansion and secure billions in capital.

Banks have quadrupled digital spending, yet customers are less happy. A new 'signal-driven' approach is changing that, and one bank's 2000% growth proves it.

A new platform combines proprietary AI with human agents to tackle healthcare's administrative mess. But can it truly streamline care and improve outcomes?

A new report on 50,000+ IT tickets reveals AI automation slashes resolution times from 3 days to 4 hours, transforming corporate productivity.

At RSAC 2026, top cyber firms are awarded for battling AI-driven attacks, deepfakes, and the next generation of digital warfare. Here's what's next.

The 3PL provider partners with IFS Softeon and Alpine to standardize operations, accelerate expansion, and enhance service for its demanding client base.

Following a record year, Knight Therapeutics is doubling its share repurchase plan. We analyze the strategy, financials, and what it means for investors.

As autonomous AI agents create a new enterprise blind spot, Straiker’s new platform gives security teams the visibility and control to tame the agentic wild west.

Genomics leader IDT launches its first IVD-grade NGS tests for cancer, aiming to standardize diagnostics and accelerate precision medicine.

A new integration allows autonomous AI agents to send SMS and emails, bridging the gap between digital intelligence and real-world action at a global scale.

Blue Heron is building homes based on your physiology. Is this the future of wellness or the ultimate luxury status symbol in a trillion-dollar market?

A new chemical admixture from Euclid Chemical allows ready-mix producers to convert returned concrete into a valuable, reusable material, boosting sustainability.